Inspire Medical Systems, Inc.
Key Metrics
- Previous Close
- $70.78
- 52-Week Range
- $38.91 – $147.03
- Market Cap
- $2.02B
- P/E (TTM)
- 15.41
- EPS (TTM)
- 4.54
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 2.45
- PEG Ratio
- —
- Return on Equity
- 17.97%
- Return on Assets
- 3.91%
- Gross Margin
- 86.13%
- Operating Margin
- -0.26%
- Profit Margin
- 15.03%
- Current Ratio
- 8.55
- Debt/Equity
- 0.04
- Total Debt
- $29.09M
- Free Cash Flow
- $94.64M
- Revenue Growth
- -7.60%
- Earnings Growth
- —
- Enterprise Value
- $1.73B
Market Snapshot
About
Inspire Medical Systems, Inc. is a medical technology company that develops and commercializes innovative solutions for obstructive sleep apnea (OSA). The company's flagship product, Inspire therapy, is an implantable neurostimulation system that works inside the body to treat OSA. The device delivers mild stimulation to key airway muscles during sleep, keeping the airway open and allowing patients to breathe normally. Inspire therapy is FDA-approved and represents the first and only neurostimulation technology for OSA, offering an alternative for patients who cannot tolerate CPAP therapy.